Advertisement
U.S. markets closed

Vivakor, Inc. (VIVK)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
0.8500+0.0092 (+1.09%)
At close: 04:00PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Hanging Man

Hanging Man

Previous Close0.8408
Open0.9200
Bid0.7007 x 1200
Ask1.0600 x 900
Day's Range0.8500 - 0.9200
52 Week Range0.4379 - 1.4800
Volume7,320
Avg. Volume69,871
Market Cap22.287M
Beta (5Y Monthly)0.60
PE Ratio (TTM)N/A
EPS (TTM)-1.1400
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for VIVK

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Vivakor, Inc.
    Analyst Report: Charles River Laboratories IntCharles River Laboratories is a non-clinical contract research organization (CRO), providing drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, and the Asia Pacific region. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions (Manufacturing). The company is headquartered in Wilmington, Massachusetts.
    Rating
    Fair Value
    Economic Moat
    16 hours agoArgus Research
View more